ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Extendicare Inc (PK)

Extendicare Inc (PK) (EXETF)

5.482
0.00
( 0.00% )
Updated: 15:53:11

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
5.482
Bid
5.51
Ask
5.53
Volume
-
0.00 Day's Range 0.00
4.10 52 Week Range 5.83
Previous Close
5.482
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
1,943
Financial Volume
-
VWAP
-
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.1182.199850857575.3645.4825.3649615.42041817CS
40.1623.045112781955.325.4825.21618615.30737137CS
12-0.016-0.2910149145145.4985.795.21619435.41282357CS
260.1923.629489603025.295.834.7436115.24024339CS
52-0.098-1.756272401435.585.834.152564.98064631CS
156-1.1986-17.94150226036.68066.774.143405.2972567CS
260-1.158-17.43975903616.647.263.4543475.24365559CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0

EXETF Discussion

View Posts
MisterEC MisterEC 9 years ago
I have traded this a number of times. Back in at 5.90 this morning. Below is a statement from the Motley Fool analyst I heard about this stock from. Unfortunate I lost track of his coverage and all my trades were done after this was released, and before I read this, except when I got back in today.

Extendicare (NASDAQOTH:EXETF) -- This was a truly unfortunate experience, as management just worked over
shareholders in a terrible way. It ran the REIT's American business into the ground and then sold it at a low point
(very much like buy high/sell low investors). The conference call announcing the deal was unbelievable, and you
could hear the anxiety in the CEO's voice as he delivered the news and parried questions from analysts. With only
a little cash going back to shareholders in the form of a stock buyback -- surely after some investors twisted
management's arm -- shareholders were right to dump the stock. It would be much more accretive to buy back stock
at these prices, but management wants to expand the business. That would be poor capital allocation.
James Royal
(TMFRoyal)
Jan 23, 2015 at 10:06AM
👍️0
clotter2 clotter2 9 years ago
Extendicare breaking resistance level. This should get good from here . LONG+
👍️0
clotter2 clotter2 9 years ago
I want to talk $EXETF $TROV.. Health-care, Biopharm, and retail...
👍️0
toddski toddski 9 years ago
Extendicare (TSE:EXE) had its price target upped by CIBC from C$7.50 to C$8.00 in a research note issued to investors on Friday. The firm currently has a sector perform rating on the stock.

http://www.mideasttime.com/extendicare-given-new-c8-00-price-target-at-cibc-exe/362393/
👍️0
toddski toddski 10 years ago
Extendicare announced 10% share buyback program:

http://finance.yahoo.com/news/extendicare-announces-intention-issue-normal-223000319.html
👍️0

Your Recent History

Delayed Upgrade Clock